Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global blood transfusion market is expected to witness a CAGR of 4.9% during the forecast period (2018-2023). The market is growing at a fast pace with the rise in accidental cases, the growing number of blood transfusion procedures, competition, and M&A activities.
Rising Accidents and Trauma Cases
Trauma is considered to be the foremost cause of death and approximately 1, 80,000 people die with trauma every year. Up to 45% of the polytrauma patients die as a result of circulatory shock from acute blood loss. The World Health Organization states that the burden of the diseases related to injuries are mostly the road traffic injuries, accidents, etc., and these accidents are expected to rise dramatically by the year 2020. Each year 1.25 million people die because of these road accidents and a large amount of blood is being lost which requires blood transfusion and ultimately leads to the growth of the market.
The other factors including the automation in blood processing equipment, the increase in the R&D initiatives for regenerative medicine, the increasing number of surgical procedures, and the rise in the number of blood disorders are also contributing to the growth of the market.
High Costs Associated with Handling of Blood
The blood supply for the transfusions is very limited as not only is the donor pool shrinking due to the aging population but also due to the stringent donor selection process, and this has ultimately increased the demand for blood transfusion. According to the American Association of Blood Banks, around 15 million units of the packed red blood cells are being transfused in the US, and around 85 million units are being transfused annually worldwide. Currently 1% of total hospital costs are attributed to blood transfusion, however, this may vary by disease and procedures. The high costs associated with the blood transfusion have restricted the growth of the blood transfusion market.
The other factors include stringent rules and regulations, like approvals needed for separation of blood components, limit the total number of end-users, thereby, reducing the market size.
North America Dominates the Market
Geographically, North America is expected to dominate the market, owing to its well-developed healthcare industry and a rise in the number of patient’s population requiring the blood. However, the Asia-Pacific region is also projected to grow at the highest growth rate due to the rising government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.
Major Players: ABBOTT, MACOPHARMA, BECTON DICKINSON, B. BRAUN MELSUNGEN AG, TERUMO MEDICAL CORPORATION, HAEMONETICS CORPORATION, FRESENIUS KABI AG, IMMUCOR, AND KIDDE-FENWAL INC., amongst others.
Reasons to Purchase this Report
• Current and future global blood transfusion market outlook in the developed and emerging markets
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The segment expected to dominate the market
• The region expected to witness the fastest growth rate during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Rising Accidents and Trauma Cases
Trauma is considered to be the foremost cause of death and approximately 1, 80,000 people die with trauma every year. Up to 45% of the polytrauma patients die as a result of circulatory shock from acute blood loss. The World Health Organization states that the burden of the diseases related to injuries are mostly the road traffic injuries, accidents, etc., and these accidents are expected to rise dramatically by the year 2020. Each year 1.25 million people die because of these road accidents and a large amount of blood is being lost which requires blood transfusion and ultimately leads to the growth of the market.
The other factors including the automation in blood processing equipment, the increase in the R&D initiatives for regenerative medicine, the increasing number of surgical procedures, and the rise in the number of blood disorders are also contributing to the growth of the market.
High Costs Associated with Handling of Blood
The blood supply for the transfusions is very limited as not only is the donor pool shrinking due to the aging population but also due to the stringent donor selection process, and this has ultimately increased the demand for blood transfusion. According to the American Association of Blood Banks, around 15 million units of the packed red blood cells are being transfused in the US, and around 85 million units are being transfused annually worldwide. Currently 1% of total hospital costs are attributed to blood transfusion, however, this may vary by disease and procedures. The high costs associated with the blood transfusion have restricted the growth of the blood transfusion market.
The other factors include stringent rules and regulations, like approvals needed for separation of blood components, limit the total number of end-users, thereby, reducing the market size.
North America Dominates the Market
Geographically, North America is expected to dominate the market, owing to its well-developed healthcare industry and a rise in the number of patient’s population requiring the blood. However, the Asia-Pacific region is also projected to grow at the highest growth rate due to the rising government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.
Major Players: ABBOTT, MACOPHARMA, BECTON DICKINSON, B. BRAUN MELSUNGEN AG, TERUMO MEDICAL CORPORATION, HAEMONETICS CORPORATION, FRESENIUS KABI AG, IMMUCOR, AND KIDDE-FENWAL INC., amongst others.
Reasons to Purchase this Report
• Current and future global blood transfusion market outlook in the developed and emerging markets
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The segment expected to dominate the market
• The region expected to witness the fastest growth rate during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
